MIAMI, April 08, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company has enrolled 50% of the patients in its ASCEND ...

MIAMI, July 29, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced that it has completed subject enrollment in its ASCEND ...

MIAMI, Feb. 12, 2026 /PRNewswire/ -- Vivex Biologics, Inc., a leading medical technology company developing and delivering innovative allografts for musculoskeletal and wound-care applications, today ...

MIAMI, May 16, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company’s Executive Chairman, John A. McCallum, has been ...

MIAMI, June 10, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the appointment of Jon E. Block, Ph.D., an industry ...

MIAMI, July 15, 2021 /PRNewswire/ -- Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatments, announced today the launch of VIA ...

MIAMI, June 16, 2023 /PRNewswire/ -- VIVEX Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatments, announced that the Centers for ...

ATLANTA and MIAMI, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced, biologically engineered tissue ...

(MENAFN- PR Newswire) MIAMI, Oct. 7, 2021 /PRNewswire/ -- Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced biologics treatment ...

(MENAFN- GlobeNewsWire - Nasdaq) Dr. Jon Block to Lead Vivex's Completion of its Ascend and Restore Randomized Clinical Trials for VIA Disc® NP, Vivex's Revolutionary Minimally Invasive Intervention ...